OCRA PRESENTS: The Importance of Genetic Testing and Biomarkers in the Changing Treatment Landscape
Thursday, September 9, 2024 from 1:00-2:30pm
Free Online Seminar
Made possible with support from AstraZeneca
Join us on September 19, 2024, for a free online seminar to learn about genetic mutations and biomarkers and discover the critical role they play in the treatment journey of ovarian, endometrial, and other related gynecologic cancers. This comprehensive program will touch on essential topics such as:
-
What is the difference between genetic mutations and biomarkers?
-
Why are biomarkers important in my treatment decisions?
-
What is maintenance therapy?
-
What is a PARP inhibitor?
-
What is targeted therapy?
Expert speakers will present the latest data on PARP inhibitors, highlighting recent changes in indications for ovarian cancer and the implications for current treatment options. Gain a clearer understanding of biomarker-specific treatments and the distinctions between advanced and maintenance therapies through this informative session.
Our online seminar will not only provide in-depth information and education but will also foster a space where the community can engage with experts and each other. Participants will have the opportunity to ask questions and seek clarification on various treatment options and recent medical developments. This no-cost event aims to empower you with knowledge and support, enhancing your treatment journey. Don’t miss this invaluable opportunity — register now to secure your place.